United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - ascorbic acid - oral tablet - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - ascorbic acid - oral tablet - 50mg

United Kingdom - English - myHealthbox

crescent pharma ltd - ascorbic acid - tablets - 50mg - ascorbic acid (vit c), plain - for the treatment of scurvy. prophylactically in cases where deficiency might be expected to occur.

United Kingdom - English - myHealthbox

crescent pharma limited - ascorbic acid - tablets - 100mg - ascorbic acid (vit c), plain - for the treatment of scurvy. prophylactically in cases where deficiency might be expected to occur

United Kingdom - English - myHealthbox

crescent pharma limited - ascorbic acid - tablets - 200mg - ascorbic acid (vit c), plain - for use in vitamin c deficiency including the treatment and prevention of scurvy

United Kingdom - English - myHealthbox

crescent pharma limited - ascorbic acid - tablets - 500mg - ascorbic acid (vit c), plain - for use in treating vitamin c deficiency including the treatment and prevention of scurvy.

Malta - English - Medicines Authority

pascoe pharmazeutische präparate gmbh schiffenberger weg 55 35394 giessen , germany - ascorbic acid - concentrate for solution for infusion or injection - ascorbic acid 7.5 g - vitamins

United States - English - NLM (National Library of Medicine)

american regent, inc. - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml

United States - English - NLM (National Library of Medicine)

fisiopharma srl - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febril states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid

United States - English - NLM (National Library of Medicine)

the torrance company - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febrile states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid.